Edwards Receives CE Mark For PASCAL Transcatheter Tricuspid Valve Repair System
Edwards Lifesciences received the CE mark for its PASCAL transcatheter system for treating triscupid valve regurgitation, competing against Abbott’s newly CE-marked TriClip.
You may also be interested in...
Part II of highlights the cardiovascular tech sectors includes news from Medtronic, Edwards Lifesciences, and Abbott, plus a look at the upcoming TCT Conference in Boston.
The next-generation TriClip G4 comes in more sizes than the original TriClip and features enhanced leaflet grasping features.
The company is sponsoring an early feasibility trial of the Intrepid transcatheter valve replacement system for patients with severe tricuspid regurgitation.